SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-166799
Filing Date
2009-08-06
Accepted
2009-08-06 12:40:43
Documents
7
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 578017
2 COMMON STOCK PURCHASE WARRANT, DATED APRIL 13, 2009 dex42.htm EX-4.2 71695
3 COMMON STOCK PURCHASE WARRANT, DATED MAY 11, 2009 dex43.htm EX-4.3 66101
4 LETTER REGARDING UNAUDITED INTERIM FINANCIAL INFORMATION dex15.htm EX-15 2364
5 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 6792
6 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 7045
7 SECTION 906 CEO AND CFO CERTIFICATION dex32.htm EX-32 6113
  Complete submission text file 0001193125-09-166799.txt   739543
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12465 | Film No.: 09990759
SIC: 2834 Pharmaceutical Preparations